|
Pediatric heart transplant process
You
can call (352) 265-0751 to make a referral to the heart
transplant program at the Shands Transplant Center at the
University of Florida.
Pediatric
heart transplantation is safe and can even be performed
on infants with otherwise lethal cardiac conditions. Most
patients are able to recover and return to society in a
productive manner.
Congenital
heart defects that could be considered for transplantation
include:
-
Hypoplastic left heart syndrome
- Single
ventricle with hypoplasia of the aortic outflow tract
- Atrioventricular
canal defect
-
Truncus arteriosus
Hypoplastic
left heart syndrome accounts for one-to-two percent of all
congenital heart disease and is the most common cause of
death from a cardiac defect during the first month of life.
These infants can benefit from an infant heart transplant
program.
Transplantation
is the only treatment that offers hope to infants with irreversible
cardiomyopathies. Currently, the indication for the vast
majority of pediatric heart recipients over the age of one
year is cardiomyopathy.
Infant
transplant patients are evaluated in the neonatal intensive
care unit or pediatric intensive care unit at Shands at
the University of Florida. Once accepted for transplantation,
the infant remains at Shands at UF until transplantation.
Infants are at significant risk of rejection, infection
and developing accelerated coronary artery disease after
heart transplantation.
Infants
receive endomyocardial biopsies at regular intervals to
check for rejection. Older children and adults receive endomyocardial
biopsies more frequently than infants.
Families
must stay within one hour's driving distance from the hospital
for the first two-to-four months following transplantation
due to the frequency and complexity of outpatient visits.
Statistics
Success rate and various other statistics regarding the
Shands Transplant Center at UF are available from the Scientific
Registry of Transplant Recipients at ustransplant.org.
Related Links
CHF
Patients
|